Fecha;Edad;Talla;Peso;ISC;GEN;TFG;TFG CALC;Medicamento 1;Medicamento 2;Medicamento 3;Medicamento 4;Medicamento 5;Medicamento 6;Medicamento 7;Medicamento 8;Medicamento 9;Medicamento 10;Medicamento 11;Medicamento 12;Medicamento 13;Medicamento 14;#;LLAMADOS PROTOCOLO;NOMBRE PROTOCOLO;Palabras en justi clinica;DX;CICLO
26/09/2024;69;1,58;66;1,74;M;Sin Cr;Sin Cr;Paclitaxel 100mg/16.7mL (6mg/mL) Sol Iny,,125,3,80,,,80,0,139,2,90%,null,,1,8,15,Frec Check;;;;;;;;;;;;;;1;PACLItaxel;Paclitaxel semanal;#N/D;Tumor maligno de la vejiga urinaria, parte no especificada;1
26/09/2024;62;1,74;80;1,99;M;Sin Cr;Sin Cr;Oxaliplatino 100mg/20mL (5mg/mL) Sol Iny,,258,7,130,,,130,0,258,7,100%,ADMINISTRAR 260 MG IV DIA 1,,1,Frec Check;;;;;;;;;;;;;;1;OXALIplatino;CAPEOX;Capec,Oxali,PLATINO;Tumor maligno del recto;1
26/09/2024;69;1,66;64;1,73;M;Sin Cr;Sin Cr;Oxaliplatino 50mg/10mL (5mg/mL) Sol Iny,,224,9,130,,,130,0,224,9,100%,null,,1,Frec Check;;;;;;;;;;;;;;1;OXALIplatino;CAPEOX;INF,XELOX;Tumor maligno del colon, parte no especificada;3
26/09/2024;66;1,55;55,6;1,57;F;Sin Cr;Sin Cr;Oxaliplatino 100mg/20mL (5mg/mL) Sol Iny,,173,5,130,FALSE,,130,0,204,1,85%,null,,1,Frec Check;;;;;;;;;;;;;;1;OXALIplatino;CAPEOX;#N/D;Tumor maligno del recto;3
26/09/2024;59;1,56;45;1,4;F;Sin Cr;Sin Cr;Oxaliplatino 100mg/20mL (5mg/mL) Sol Iny,,180,0,180,,,130,0,182,0,99%,Oxaliplatino (130 mg/m2). Dosis calculada 180 mg IV. Administrar el dÃ­a 1 de cada ciclo.,,1,Frec Check;Oxaliplatino 100mg/20mL (5mg/mL) Sol Iny,,180,180,,,130,182,0,99%,Oxaliplatino (130 mg/m2). Dosis calculada 180 mg IV. Administrar el dÃ­a 1 de cada ciclo.;Oxaliplatino 100mg/20mL (5mg/mL) Sol Iny,,180,180,,,130,0,182,0,99%,Oxaliplatino (130 mg/m2). Dosis calculada 180 mg IV. Administrar el dÃ­a 1 de cada ciclo.;;;;;;;;;;;;3;OXALIplatino,OXALIplatino,OXALIplatino;CAPEOX;Capec,CAPEOX,INF,Oxali,PLATINO, SC,AJUSTE,AJUST,CREA,CREAT;Tumor maligno del recto;1
26/09/2024;77;1,61;49,5;1,49;M;Sin Cr;Sin Cr;Oxaliplatino 50mg/10mL (5mg/mL) Sol Iny,,150,0,150,TRUE,Dosis fija,130,0,150,0,100%,150 mg DOSIS FIJA,,1,Frec Check;;;;;;;;;;;;;;1;OXALIplatino;CAPEOX;#N/D;Tumor maligno del estomago, parte no especificada;5
27/09/2024;37;1,62;71;1,82;F;Sin Cr;Sin Cr;Trastuzumab Emtansina 100mg Polv iny,,255,6,4,,,3,6,255,6,100%,null,,1,21,Inconsistente, según proto: 1;Trastuzumab Emtansina 160mg Polv Iny,,255,6,3,6,,,4,255,6,100%,null;;;;;;;;;;;;;2;Trastuzumab_Emtansina,Trastuzumab_Emtansina;Emilia; SC,AJUSTE,AJUST;Tumor maligno de la mama, parte no especificada;5
27/09/2024;58;1,74;52,1;1,57;M;Sin Cr;Sin Cr;Fluorouracilo 500 mg/10mL (50mg/mL) Sol Iny,,3.768,0,2.400,,,2.400,0,3768,0,100%,null,,1,15,Frec Check;Fluorouracilo 500 mg/10mL (50mg/mL) Sol Iny,,628,400,,,400,628,0,100%,null;Oxaliplatino 50mg/10mL (5mg/mL) Sol Iny,,106,76,85,FALSE,,85,0,133,5,80%,null;Calcio folinato 50mg/5mL (10mg/mL) Sol Iny,,628,400,,,400,628,0,100%,null;;;;;;;;;;;4;Fluorouracilo,Fluorouracilo,OXALIplatino,Folinato;FOLFOX6modif;#N/D;Tumor maligno del estomago, parte no especificada;7
27/09/2024;69;1,77;68;1,83;M;Sin Cr;Sin Cr;Docetaxel 20mg/mL Sol Iny,,135,8,75,,,75,0,137,3,99%,null,,1,Frec Check;;;;;;;;;;;;;;1;DOCEtaxel;Docetaxel monoQT;#N/D;Tumor maligno de la prostata;3
27/09/2024;60;1,53;53;1,53;F;Sin Cr;Sin Cr;Ciclofosfamida 500mg  Polv Iny,,924,0,600,,,600,0,918,0,101%,null,,1,Frec Check;Doxorrubicina 50mg/25mL (2mg/mL) Sol Iny,,92,4,60,,,60,91,8,101%,null;;;;;;;;;;;;;2;CICLOfosfamida,DOXOrubicina;AC; AC , GC ,INF,40%,100%;Tumor maligno de la mama, parte no especificada;3
28/09/2024;70;1,58;57;1,6;F;Sin Cr;Sin Cr;Oxaliplatino 100mg/20mL (5mg/mL) Sol Iny,,208,0,130,,,130,0,208,0,100%,null,,1,Frec Check;;;;;;;;;;;;;;1;OXALIplatino;CAPEOX;CAPEOX,VIDE,XELOX,CREA,CREAT;Tumor maligno del colon, parte no especificada;2
28/09/2024;64;1,6;76;1,88;F;Sin Cr;Sin Cr;Paclitaxel 100mg/16.7mL (6mg/mL) Sol Iny,,150,4,80,,,80,0,150,4,100%,null,,1,8,15,Frec Check;;;;;;;;;;;;;;1;PACLItaxel;Paclitaxel semanal;INF,5%,75%,80%;Tumor maligno de la mama, parte no especificada;1
28/09/2024;41;1,55;60;1,64;F;Sin Cr;Sin Cr;Docetaxel 20mg/mL Sol Iny,,123,0,75,,,75,0,123,0,100%,null,,1,Frec Check;;;;;;;;;;;;;;1;DOCEtaxel;Docetaxel monoQT;DOCE, GC ,INF, RT ,TAXANO,20%;Tumor maligno de la mama, parte no especificada;2
28/09/2024;33;1,6;63;1,7;F;Sin Cr;Sin Cr;Pertuzumab 420mg/14mL (30mg/mL) Sol Iny,,420,0,420,TRUE,,840,0,420,0,100%,,Pertuzumab 420mg. Administrar dÃ­a 1.,,1,Frec Check;Trastuzumab 440mg Polv Iny,,380,380,,,6,378,0,101%,Trastuzumab (6 mg/kg). Dosis calculada 380 mg/IV, Administrar dÃ­a 1.;;;;;;;;;;;;;2;PERTUzumab,TRAStuzumab;cleopatra trastuzu IV;PERTU, SC,TrastU,CREA,CREAT;Tumor maligno de la mama, parte no especificada;3
28/09/2024;47;1,7;76;1,92;M;Sin Cr;Sin Cr;Oxaliplatino 100mg/20mL (5mg/mL) Sol Iny,,192,0,100,TRUE,,130,0,192,0,100%,null,,1,Frec Check;;;;;;;;;;;;;;1;OXALIplatino;CAPEOX;Capec,INF,Oxali,PLATINO, SC,XELOX,AJUSTE,AJUST,100%,CREA,CREAT;Tumor maligno del recto;3
30/09/2024;62;1,8;48;1,52;M;Sin Cr;Sin Cr;Fluorouracilo 500 mg/10mL (50mg/mL) Sol Iny,,3.648,0,2.400,,,2.400,0,3648,0,100%,null,,1,15,Frec Check;Fluorouracilo 500 mg/10mL (50mg/mL) Sol Iny,,608,400,,,400,608,0,100%,null;Oxaliplatino 100mg/20mL (5mg/mL) Sol Iny,,129,2,85,,,85,0,129,2,100%,null;Oxaliplatino 50mg/10mL (5mg/mL) Sol Iny,,129,2,85,,,85,129,2,100%,null;Calcio folinato 50mg/5mL (10mg/mL) Sol Iny,,608,400,,,400,608,0,100%,null;;;;;;;;;;5;Fluorouracilo,Fluorouracilo,OXALIplatino,OXALIplatino,Folinato;FOLFOX6modif;FOLFOX,INF;Tumor maligno del esofago, parte no especificada;1
30/09/2024;34;1,54;77,2;1,88;F;Sin Cr;Sin Cr;Paclitaxel 30mg/5mL (6mg/mL) Sol Iny,,150,4,80,,,80,0,150,4,100%,null,,1,8,15,Frec Check;Paclitaxel 100mg/16.7mL (6mg/mL) Sol Iny,,150,4,80,,,80,150,4,100%,null;;;;;;;;;;;;;2;PACLItaxel,PACLItaxel;Paclitaxel semanal;#N/D;Tumor maligno de la mama, parte no especificada;1
30/09/2024;36;1,62;59;1,65;F;Sin Cr;Sin Cr;Ciclofosfamida 1gr (1000mg) Polv Iny,,990,0,600,,,600,0,990,0,100%,null,,1,15,Inconsistente, según proto: 1;Doxorrubicina 50mg/25mL (2mg/mL) Sol Iny,,99,60,,,60,99,0,100%,null;;;;;;;;;;;;;2;Ciclofosfamida,DOXOrubicina;AC; AC ,INF, SC,60%;Tumor maligno de la mama, parte no especificada;1
30/09/2024;64;1,61;67,8;1,77;M;Sin Cr;Sin Cr;Docetaxel 20mg/mL Sol Iny,,132,8,75,,,75,0,132,8,100%,null,,1,Frec Check;;;;;;;;;;;;;;1;DOCEtaxel;Docetaxel monoQT;DOCE, RT , SC;Tumor maligno de la prostata;4
30/09/2024;65;1,68;60;1,68;M;Sin Cr;Sin Cr;Fluorouracilo 500 mg/10mL (50mg/mL) Sol Iny,,4.032,0,2.400,,,2.400,0,4032,0,100%,null,,1,15,Frec Check;Fluorouracilo 500 mg/10mL (50mg/mL) Sol Iny,,672,400,,,400,672,0,100%,null;Oxaliplatino 100mg/20mL (5mg/mL) Sol Iny,,142,8,85,,,85,0,142,8,100%,null;Oxaliplatino 50mg/10mL (5mg/mL) Sol Iny,,142,8,85,,,85,142,8,100%,null;Calcio folinato 50mg/5mL (10mg/mL) Sol Iny,,672,400,,,400,672,0,100%,null;;;;;;;;;;5;Fluorouracilo,Fluorouracilo,OXALIplatino,OXALIplatino,Folinato;FOLFOX6modif;FOLFOX,INF;Tumor maligno del estomago, parte no especificada;1
30/09/2024;59;1,52;59;1,62;F;Sin Cr;Sin Cr;Oxaliplatino 50mg/10mL (5mg/mL) Sol Iny,,179,0,130,,,130,0,210,6,85%,,,,1,Frec Check;;;;;;;;;;;;;;1;OXALIplatino;CAPEOX;Capec,INF,Oxali,PLATINO, RT ,XELOX,AJUSTE,AJUST;Tumor maligno del recto;4
30/09/2024;66;1,53;88;2,01;F;Sin Cr;Sin Cr;Pertuzumab 420mg/14mL (30mg/mL) Sol Iny,,420,0,420,TRUE,,840,0,420,0,100%,null,,1,Frec Check;Trastuzumab 440mg Polv Iny,,528,6,,,6,528,0,100%,null;;;;;;;;;;;;;2;PERTUzumab,TRAStuzumab;cleopatra trastuzu IV;PERTU,TRAIN ,TrastU;Tumor maligno de la mama, parte no especificada;8
30/09/2024;67;1,5;51;1,49;F;Sin Cr;Sin Cr;Ciclofosfamida 500mg  Polv Iny,,894,0,600,,,600,0,894,0,100%,null,,1,Frec Check;Doxorrubicina 50mg/25mL (2mg/mL) Sol Iny,,89,4,60,,,60,89,4,100%,null;;;;;;;;;;;;;2;CICLOfosfamida,DOXOrubicina;AC; AC ,CICLOF,DOXO,DOXO,INF, SC,20%,100%;Tumor maligno de la mama, parte no especificada;4
30/09/2024;62;1,51;69;1,76;F;Sin Cr;Sin Cr;Ciclofosfamida 500mg  Polv Iny,,978,0,600,,,600,0,1056,0,93%,null,,1,Frec Check;Doxorrubicina 50mg/25mL (2mg/mL) Sol Iny,,97,8,60,,,60,105,6,93%,null;;;;;;;;;;;;;2;CICLOfosfamida,DOXOrubicina;AC; AC ,40%,100%;Tumor maligno de la mama, parte no especificada;2
30/09/2024;74;1,59;53;1,54;F;Sin Cr;Sin Cr;Oxaliplatino 100mg/20mL (5mg/mL) Sol Iny,,200,2,130,,,130,0,200,2,100%,null,,1,Frec Check;;;;;;;;;;;;;;1;OXALIplatino;CAPEOX;Capec,EMA CO,INF,Oxali,PLATINO,XELOX,100%,CREA,CREAT;Tumor maligno del recto;4
30/09/2024;58;1,51;64;1,69;F;Sin Cr;Sin Cr;Pertuzumab 420mg/14mL (30mg/mL) Sol Iny,,420,0,420,TRUE,,840,0,420,0,100%,null,,1,Frec Check;Trastuzumab 440mg Polv Iny,,354,6,,,6,384,0,92%,null;;;;;;;;;;;;;2;PERTUzumab,TRAStuzumab;cleopatra trastuzu IV;Capec,cleopatra,Cleopatra,INF,PERTU,TrastU,VIDE,80%,90%;Tumor maligno de la mama, parte no especificada;3
30/09/2024;61;1,54;67;1,74;F;Sin Cr;Sin Cr;Pertuzumab 420mg/14mL (30mg/mL) Sol Iny,,420,0,420,TRUE,,840,0,420,0,100%,null,,1,22,Inconsistente, según proto: 1;Trastuzumab 440mg Polv Iny,,402,6,,,6,402,0,100%,null;;;;;;;;;;;;;2;PERTUzumab,TRAStuzumab;cleopatra trastuzu IV; CAP ;Tumor maligno de la mama, parte no especificada;8
30/09/2024;49;1,53;55;1,56;F;Sin Cr;Sin Cr;Trastuzumab Emtansina 100mg Polv iny,,198,0,4,,,3,6,198,0,100%,null,,1,Frec Check;;;;;;;;;;;;;;1;Trastuzumab_Emtansina;Emilia;INF,TrastU,CREA,CREAT;Tumor maligno de la mama, parte no especificada;1
30/09/2024;44;1,58;54;1,56;F;Sin Cr;Sin Cr;Paclitaxel 100mg/16.7mL (6mg/mL) Sol Iny,,106,3,125,,,80,0,124,8,85%,ajuste del  15 %,,1,8,15,Frec Check;;;;;;;;;;;;;;1;PACLItaxel;Paclitaxel semanal;PACLI,semanal,TAXANO,AJUST,5%,15%;Tumor maligno de la mama, parte no especificada;1
30/09/2024;40;1,58;69;1,78;F;Sin Cr;Sin Cr;Trastuzumab Emtansina 160mg Polv Iny,,248,4,4,,,3,6,248,4,100%,null,,1,22,Inconsistente, según proto: 1;;;;;;;;;;;;;;1;Trastuzumab_Emtansina;Emilia;cleopatra,Cleopatra,DOCE,INF,60%;Tumor maligno de la mama, parte no especificada;2
30/09/2024;63;1,65;90;2,08;M;Sin Cr;Sin Cr;Docetaxel 20mg/mL Sol Iny,,157,5,75,,,75,0,156,0,101%,null,,1,Frec Check;;;;;;;;;;;;;;1;DOCEtaxel;Docetaxel monoQT;DOCE,INF;Tumor maligno de la prostata;4
30/09/2024;51;1,68;62;1,71;M;Sin Cr;Sin Cr;Fluorouracilo 500 mg/10mL (50mg/mL) Sol Iny,,4.104,0,2.400,,,2.400,0,4104,0,100%,null,,1,15,Frec Check;Fluorouracilo 500 mg/10mL (50mg/mL) Sol Iny,,684,400,,,400,684,0,100%,null;Oxaliplatino 50mg/10mL (5mg/mL) Sol Iny,,145,35,85,,,85,0,145,4,100%,null;Calcio folinato 50mg/5mL (10mg/mL) Sol Iny,,684,400,,,400,684,0,100%,null;;;;;;;;;;;4;Fluorouracilo,Fluorouracilo,OXALIplatino,Folinato;FOLFOX6modif;#N/D;Tumor maligno del recto;8
1/10/2024;21;1,75;59;1,69;M;Sin Cr;Sin Cr;Oxaliplatino 50mg/10mL (5mg/mL) Sol Iny,,219,7,130,,,130,0,219,7,100%,,,,,1,Frec Check;;;;;;;;;;;;;;1;OXALIplatino;CAPEOX;Capec,CAPEOX,Oxali,PLATINO;Tumor maligno del recto;1
1/10/2024;27;1,58;51,7;1,52;F;Sin Cr;Sin Cr;Ciclofosfamida 1gr (1000mg) Polv Iny,,800,0,800,FALSE,,600,0,912,0,88%,null,,1,Frec Check;Doxorrubicina 50mg/25mL (2mg/mL) Sol Iny,,80,80,,,60,91,2,88%,null;Pembrolizumab 100mg/4mL (25mg/mL) Sol Iny,,200,200,,,200,0,200,0,100%,null;;;;;;;;;;;;3;Ciclofosfamida,DOXOrubicina,PEMBROlizumab;AC; AC ,AC IO,CICLOF,DOXO,DOXO,PEMBRO, SC,AJUST,10%;Tumor maligno de la mama, parte no especificada;1
1/10/2024;74;1,7;87;2,07;M;Sin Cr;Sin Cr;Docetaxel 20mg/mL Sol Iny,,120,0,120,FALSE,60,00,75,0,124,2,97%,Dosis calculada 120 mg IV. Administrar en infusiÃ³n de 60 minutos el dÃ­a 1.,,1,Frec Check;;;;;;;;;;;;;;1;DOCEtaxel;Docetaxel monoQT; AC ,DOCE,INF,TAXANO,AJUST;Tumor maligno de la prostata;9
1/10/2024;74;1,7;68;1,81;M;Sin Cr;Sin Cr;Docetaxel 20mg/mL Sol Iny,,133,5,75,,,75,0,135,8,98%,null,,1,Frec Check;;;;;;;;;;;;;;1;DOCEtaxel;Docetaxel monoQT;DOCE,INF,5%;Tumor maligno de la prostata;2
1/10/2024;68;1,69;62;1,71;M;Sin Cr;Sin Cr;Oxaliplatino 50mg/10mL (5mg/mL) Sol Iny,,222,3,130,,,130,0,222,3,100%,,,,1,Frec Check;;;;;;;;;;;;;;1;OXALIplatino;CAPEOX;Capec,INF,Oxali,PLATINO;Tumor maligno del recto;1
1/10/2024;40;1,52;81;1,92;F;Sin Cr;Sin Cr;Paclitaxel 100mg/16.7mL (6mg/mL) Sol Iny,,130,6,80,,,80,0,153,6,85%,null,,1,8,15,Frec Check;;;;;;;;;;;;;;1;PACLItaxel;Paclitaxel semanal;CICLOF,DOXO,DOXO,PACLI, SC,TAXANO,AJUST,5%,15%;Tumor maligno de la mama, parte no especificada;1
1/10/2024;68;1,55;55;1,56;F;Sin Cr;Sin Cr;Trastuzumab Emtansina 100mg Polv iny,,198,0,4,,,3,6,198,0,100%,Administrar 198 mg iv dia 1,,1,Frec Check;;;;;;;;;;;;;;1;Trastuzumab_Emtansina;Emilia;#N/D;Tumor maligno de la mama, parte no especificada;5
1/10/2024;56;1,5;58,6;1,6;F;Sin Cr;Sin Cr;Doxorrubicina 50mg/25mL (2mg/mL) Sol Iny,,96,0,60,,,60,0,96,0,100%,null,,1,Frec Check;Ciclofosfamida 500mg  Polv Iny,,960,600,,,600,960,0,100%,null;;;;;;;;;;;;;2;DOXOrubicina,CICLOfosfamida;AC;#N/D;Tumor maligno de la mama, parte no especificada;1
1/10/2024;51;1,56;56;1,58;F;Sin Cr;Sin Cr;Trastuzumab Emtansina 100mg Polv iny,,201,6,4,,,3,6,201,6,100%,Administrar 198 mg iv dia 1,,1,Frec Check;;;;;;;;;;;;;;1;Trastuzumab_Emtansina;Emilia;#N/D;Tumor maligno de la mama, parte no especificada;4
1/10/2024;51;1,54;76;1,86;F;Sin Cr;Sin Cr;Pertuzumab 420mg/14mL (30mg/mL) Sol Iny,,420,0,420,TRUE,,840,0,420,0,100%,null,,1,Frec Check;Trastuzumab 440mg Polv Iny,,456,6,,,6,456,0,100%,APLICAR 440 MG DIA 1;;;;;;;;;;;;;2;PERTUzumab,TRAStuzumab;cleopatra trastuzu IV;PERTU,TrastU;Tumor maligno de la mama, parte no especificada;7
1/10/2024;46;1,54;60;1,64;F;Sin Cr;Sin Cr;Paclitaxel 100mg/16.7mL (6mg/mL) Sol Iny,,131,2,80,,,80,0,131,2,100%,null,,1,8,15,Frec Check;;;;;;;;;;;;;;1;PACLItaxel;Paclitaxel semanal; AC ,PACLI,TAXANO,100%;Tumor maligno de la mama, parte no especificada;1
1/10/2024;39;1,75;71;1,87;F;Sin Cr;Sin Cr;Calcio folinato 50mg/5mL (10mg/mL) Sol Iny,,635,8,400,,,400,0,748,0,85%,Administrar 635 mg iv dia 1,15,,1,15,Frec Check;Fluorouracilo 500 mg/10mL (50mg/mL) Sol Iny,,635,8,400,,,400,748,0,85%,Administrar 635 mg iv dia 1,15;Oxaliplatino 100mg/20mL (5mg/mL) Sol Iny,,158,95,85,,,85,0,159,0,100%,administrar 160 mg iv dia 1,15;Fluorouracilo 500 mg/10mL (50mg/mL) Sol Iny,,3814,8,2400,,,2.400,4488,0,85%,Administrar  3800 mg iv dia 1,15;;;;;;;;;;;4;Folinato,Fluorouracilo,OXALIplatino,Fluorouracilo;FOLFOX6modif;FOLFOX,AJUST,5%,15%,CREA,CREAT;Tumor maligno del colon, parte no especificada;6
1/10/2024;56;1,68;73;1,87;M;Sin Cr;Sin Cr;Oxaliplatino 100mg/20mL (5mg/mL) Sol Iny,,243,1,130,,,130,0,243,1,100%,null,,1,Frec Check;;;;;;;;;;;;;;1;OXALIplatino;CAPEOX;TC ,5%;Tumor maligno del colon, parte no especificada;1
2/10/2024;40;1,81;83;2,05;M;Sin Cr;Sin Cr;Oxaliplatino 50mg/10mL (5mg/mL) Sol Iny,,266,5,130,,,130,0,266,5,100%,,,,1,Frec Check;;;;;;;;;;;;;;1;OXALIplatino;CAPEOX;Capec,INF,Oxali,PLATINO, SC,XELOX,100%;Tumor maligno del recto;3
2/10/2024;38;1,63;61,8;1,69;F;Sin Cr;Sin Cr;Paclitaxel 30mg/5mL (6mg/mL) Sol Iny,,135,2,80,,,80,0,135,2,100%,null,,1,8,15,Frec Check;Paclitaxel 100mg/16.7mL (6mg/mL) Sol Iny,,135,2,80,,,80,135,2,100%,null;;;;;;;;;;;;;2;PACLItaxel,PACLItaxel;Paclitaxel semanal;PACLI, SC,CREA,CREAT;Tumor maligno de la mama, parte no especificada;1
2/10/2024;74;1,71;73;1,88;M;Sin Cr;Sin Cr;Fluorouracilo 500 mg/10mL (50mg/mL) Sol Iny,,4.512,0,2.400,,,2.400,0,4512,0,100%,null,,1,15,Frec Check;Fluorouracilo 500 mg/10mL (50mg/mL) Sol Iny,,752,400,,,400,752,0,100%,null;Oxaliplatino 100mg/20mL (5mg/mL) Sol Iny,,159,8,85,,,85,0,159,8,100%,null;Oxaliplatino 50mg/10mL (5mg/mL) Sol Iny,,159,8,85,,,85,159,8,100%,null;Calcio folinato 50mg/5mL (10mg/mL) Sol Iny,,752,400,,,400,752,0,100%,null;;;;;;;;;;5;Fluorouracilo,Fluorouracilo,OXALIplatino,OXALIplatino,Folinato;FOLFOX6modif;#N/D;Tumor maligno del colon, parte no especificada;5
2/10/2024;54;1,48;55;1,54;F;Sin Cr;Sin Cr;Trastuzumab 440mg Polv Iny,,330,0,6,,,6,0,330,0,100%,null,,1,Frec Check;Pertuzumab 420mg/14mL (30mg/mL) Sol Iny,,420,420,TRUE,,840,420,0,100%,null;Trastuzumab 440mg Polv Iny,,330,6,,,6,0,330,0,100%,null;Trastuzumab 440mg Polv Iny,,330,6,,,6,330,0,100%,null;Trastuzumab 440mg Polv Iny,,330,6,,,6,330,0,100%,null;;;;;;;;;;5;TRAStuzumab,PERTUzumab,TRAStuzumab,TRAStuzumab,TRAStuzumab;cleopatra trastuzu IV;PERTU,TrastU,80%;Tumor maligno de la mama, parte no especificada;76
2/10/2024;57;1,55;59;1,63;F;Sin Cr;Sin Cr;Trastuzumab 440mg Polv Iny,,472,0,8,TRUE,,6,0,472,0,100%,null,,1,Frec Check;Pertuzumab 420mg/14mL (30mg/mL) Sol Iny,,840,840,,,840,840,0,100%,DOSIS CARGA;;;;;;;;;;;;;2;TRAStuzumab,PERTUzumab;cleopatra trastuzu IV; CAP ,INF,PERTU,TAXANO,TrastU,100%;Tumor maligno de la mama, parte no especificada;1
2/10/2024;83;1,45;49;1,44;F;Sin Cr;Sin Cr;Pertuzumab 420mg/14mL (30mg/mL) Sol Iny,,420,0,420,TRUE,,840,0,420,0,100%,null,,1,Frec Check;Trastuzumab 440mg Polv Iny,,300,6,,,6,294,0,102%,null;;;;;;;;;;;;;2;PERTUzumab,TRAStuzumab;cleopatra trastuzu IV;#N/D;Tumor maligno de la mama, parte no especificada;5
2/10/2024;77;1,55;60;1,64;F;Sin Cr;Sin Cr;Pertuzumab 420mg/14mL (30mg/mL) Sol Iny,,420,0,420,TRUE,,840,0,420,0,100%,null,,1,22,Inconsistente, según proto: 1;Trastuzumab 440mg Polv Iny,,337,8,6,,,6,360,0,94%,null;;;;;;;;;;;;;2;PERTUzumab,TRAStuzumab;cleopatra trastuzu IV;PERTU, SC,TrastU;Tumor maligno de la mama, parte no especificada;18
2/10/2024;67;1,62;54;1,57;F;Sin Cr;Sin Cr;Pertuzumab 420mg/14mL (30mg/mL) Sol Iny,FALSE,420,0,420,TRUE,,840,0,420,0,100%,PERTUZUMAB 420 MG IV DÃA 1 Y 21,,1,21,Inconsistente, según proto: 1;Trastuzumab 440mg Polv Iny,,324,6,,,6,324,0,100%,null;;;;;;;;;;;;;2;PERTUzumab,TRAStuzumab;cleopatra trastuzu IV;DOCE,INF,PERTU,TrastU,VIDE,30%;Tumor maligno de la mama, parte no especificada;1
2/10/2024;80;1,46;61;1,63;F;Sin Cr;Sin Cr;Doxorrubicina 50mg/25mL (2mg/mL) Sol Iny,,83,1,60,,,60,0,97,8,85%,null,,1,Frec Check;Ciclofosfamida 500mg  Polv Iny,,831,3,600,,,600,978,0,85%,null;;;;;;;;;;;;;2;DOXOrubicina,CICLOfosfamida;AC;#N/D;Tumor maligno de la mama, parte no especificada;1
2/10/2024;65;1,58;96;2,13;F;Sin Cr;Sin Cr;Oxaliplatino 100mg/20mL (5mg/mL) Sol Iny,,260,0,260,,,130,0,276,9,94%,130 mg/m2 IV dia 1, calculado con SC 2,,1,Frec Check;;;;;;;;;;;;;;1;OXALIplatino;CAPEOX;#N/D;Tumor maligno del recto;4
2/10/2024;56;1,5;78;1,87;F;Sin Cr;Sin Cr;Paclitaxel 100mg/16.7mL (6mg/mL) Sol Iny,,149,6,80,,,80,0,149,6,100%,null,,1,8,15,Frec Check;;;;;;;;;;;;;;1;PACLItaxel;Paclitaxel semanal; AC ,INF,semanal,TAXANO,80%,100%;Tumor maligno de la mama, parte no especificada;4
2/10/2024;49;1,53;55;1,56;F;Sin Cr;Sin Cr;Trastuzumab 440mg Polv Iny,,330,0,6,,,6,0,330,0,100%,null,,1,22,Inconsistente, según proto: 1;Pertuzumab 420mg/14mL (30mg/mL) Sol Iny,,420,420,TRUE,,840,420,0,100%,null;;;;;;;;;;;;;2;TRAStuzumab,PERTUzumab;cleopatra trastuzu IV;#N/D;Tumor maligno de la mama, parte no especificada;1
2/10/2024;48;1,59;65;1,73;F;Sin Cr;Sin Cr;Trastuzumab Emtansina 160mg Polv Iny,,234,0,3,,,3,6,234,0,100%,null,,1,Frec Check;Trastuzumab Emtansina 100mg Polv iny,,234,3,,,4,234,0,100%,null;;;;;;,,,,,,,,;;;;;;;2;Trastuzumab_Emtansina,Trastuzumab_Emtansina;Emilia; AC , CAP , GC ,PACLI, RT ,TrastU,40%,100%;Tumor maligno de la mama, parte no especificada;1
2/10/2024;43;1,6;64;1,72;F;Sin Cr;Sin Cr;Trastuzumab Emtansina 100mg Polv iny,,192,0,3,TRUE,,3,6,192,0,100%,null,,1,21,Inconsistente, según proto: 1;;;;;;;;;;;;;;1;Trastuzumab_Emtansina;Emilia;VIDE,AJUSTE,AJUST,100%;Tumor maligno de la mama, parte no especificada;1
2/10/2024;40;1,53;65;1,71;F;Sin Cr;Sin Cr;Ciclofosfamida 500mg  Polv Iny,,1.000,0,1.000,,,600,0,1026,0,97%,null,,1,Frec Check;Doxorrubicina 50mg/25mL (2mg/mL) Sol Iny,,100,100,,,60,102,6,97%,null;;;;;;;;;;;;;2;CICLOfosfamida,DOXOrubicina;AC; AC ,CICLOF,DOXO,DOXO, SC;Tumor maligno de la mama, parte no especificada;1
2/10/2024;61;1,69;79;1,96;M;Sin Cr;Sin Cr;Fluorouracilo 500 mg/10mL (50mg/mL) Sol Iny,,4.704,0,2.400,,,2.400,0,4704,0,100%,null,,1,15,Frec Check;Fluorouracilo 500 mg/10mL (50mg/mL) Sol Iny,,784,400,,,400,784,0,100%,null;Oxaliplatino 100mg/20mL (5mg/mL) Sol Iny,,133,28,85,,,85,0,166,6,80%,null;Oxaliplatino 50mg/10mL (5mg/mL) Sol Iny,,133,28,85,,,85,166,6,80%,null;Calcio folinato 50mg/5mL (10mg/mL) Sol Iny,,784,400,,,400,784,0,100%,null;;;;;;;;;;5;Fluorouracilo,Fluorouracilo,OXALIplatino,OXALIplatino,Folinato;FOLFOX6modif;Capec,FOLFOX,MAYO ,Oxali,PLATINO,AJUSTE,AJUST,20%;Tumor maligno del colon, parte no especificada;2
2/10/2024;63;1,7;69;1,82;M;Sin Cr;Sin Cr;Oxaliplatino 50mg/10mL (5mg/mL) Sol Iny,,241,8,130,,,130,0,236,6,102%,null,,1,Frec Check;;;;;;;;;;;;;;1;OXALIplatino;CAPEOX;Capec,XELOX;Tumor maligno del recto;3
3/10/2024;62;1,74;77;1,95;M;Sin Cr;Sin Cr;Calcio folinato 50mg/5mL (10mg/mL) Sol Iny,,768,0,400,,,400,0,780,0,98%,,,,,1,15,Frec Check;Fluorouracilo 500 mg/10mL (50mg/mL) Sol Iny,,768,400,,,400,780,0,98%,.;Oxaliplatino 50mg/10mL (5mg/mL) Sol Iny,,163,2,85,,,85,0,165,8,98%,,;Fluorouracilo 500 mg/10mL (50mg/mL) Sol Iny,,4680,2400,,,2.400,4680,0,100%,null;;;;;;;;;;;4;Folinato,Fluorouracilo,OXALIplatino,Fluorouracilo;FOLFOX6modif;Beva,FLUORO,FOLFOX,VIDE;Tumor maligno del colon, parte no especificada;2
3/10/2024;70;1,73;73,3;1,89;M;Sin Cr;Sin Cr;Fluorouracilo 500 mg/10mL (50mg/mL) Sol Iny,,4.536,0,2.400,,,2.400,0,4536,0,100%,null,,1,15,Frec Check;Fluorouracilo 500 mg/10mL (50mg/mL) Sol Iny,,756,400,,,400,756,0,100%,null;Oxaliplatino 100mg/20mL (5mg/mL) Sol Iny,,160,65,85,,,85,0,160,7,100%,null;Oxaliplatino 50mg/10mL (5mg/mL) Sol Iny,,160,65,85,,,85,160,7,100%,null;Calcio folinato 50mg/5mL (10mg/mL) Sol Iny,,756,400,,,400,756,0,100%,null;;;;;;;;;;5;Fluorouracilo,Fluorouracilo,OXALIplatino,OXALIplatino,Folinato;FOLFOX6modif;#N/D;Tumor maligno del estomago, parte no especificada;2
3/10/2024;67;1,7;57;1,64;M;Sin Cr;Sin Cr;Docetaxel 20mg/mL Sol Iny,,123,0,75,,,75,0,123,0,100%,null,,1,Frec Check;;;;;;;;;;;;;;1;DOCEtaxel;Docetaxel monoQT;DOCE,INF, SC;Tumor maligno de la prostata;1
3/10/2024;68;1,6;58,3;1,63;F;Sin Cr;Sin Cr;Calcio folinato 50mg/5mL (10mg/mL) Sol Iny,,554,2,400,,,400,0,652,0,85%,null,,1,15,Frec Check;Fluorouracilo 500 mg/10mL (50mg/mL) Sol Iny,,554,2,400,,,400,652,0,85%,null;Oxaliplatino 100mg/20mL (5mg/mL) Sol Iny,,124,7,85,,,85,0,138,6,90%,;Oxaliplatino 50mg/10mL (5mg/mL) Sol Iny,,124,7,85,,,85,138,6,90%,null;Fluorouracilo 500 mg/10mL (50mg/mL) Sol Iny,,3325,2,2400,,,2.400,3912,0,85%,null;;;;;;;;;;5;Folinato,Fluorouracilo,OXALIplatino,OXALIplatino,Fluorouracilo;FOLFOX6modif;FOLFOX,VIDE,AJUSTE,AJUST;Tumor maligno del estomago, parte no especificada;7
3/10/2024;62;1,64;84;2;F;Sin Cr;Sin Cr;Oxaliplatino 100mg/20mL (5mg/mL) Sol Iny,,260,0,130,,,130,0,260,0,100%,null,,1,Frec Check;;;;;;;;;;;;;;1;OXALIplatino;CAPEOX;Capec,CONCURRENTE,INF,XELOX;Tumor maligno del recto;1
3/10/2024;59;1,41;40;1,27;F;Sin Cr;Sin Cr;Pertuzumab 420mg/14mL (30mg/mL) Sol Iny,,420,0,420,TRUE,,840,0,420,0,100%,null,,1,Frec Check;Trastuzumab 440mg Polv Iny,,240,6,,,6,240,0,100%,null;;;;;;;;;;;;;2;PERTUzumab,TRAStuzumab;cleopatra trastuzu IV;PERTU,TrastU,5%,60%;Tumor maligno de la mama, parte no especificada;27
3/10/2024;77;1,52;77,9;1,88;F;Sin Cr;Sin Cr;Ciclofosfamida 500mg  Polv Iny,,902,4,600,,,600,0,1128,0,80%,null,,1,Frec Check;Doxorrubicina 50mg/25mL (2mg/mL) Sol Iny,,90,24,60,,,60,112,8,80%,null;;;;;;;;;;;;;2;CICLOfosfamida,DOXOrubicina;AC;#N/D;Tumor maligno de la mama, parte no especificada;1
3/10/2024;75;1,54;48,3;1,45;F;Sin Cr;Sin Cr;Fluorouracilo 500 mg/10mL (50mg/mL) Sol Iny,,435,0,400,,,400,0,580,0,75%,null,,1,15,Frec Check;Fluorouracilo 500 mg/10mL (50mg/mL) Sol Iny,,435,400,,,400,580,0,75%,null;Oxaliplatino 50mg/10mL (5mg/mL) Sol Iny,,92,44,85,,,85,0,123,3,75%,null;Calcio folinato 50mg/5mL (10mg/mL) Sol Iny,,580,400,,,400,580,0,100%,null;;;;;;;;;;;4;Fluorouracilo,Fluorouracilo,OXALIplatino,Folinato;FOLFOX6modif;FOLFOX,AJUSTE,AJUST,5%,25%;Tumor maligno del estomago, parte no especificada;5
3/10/2024;69;1,5;62;1,65;F;Sin Cr;Sin Cr;Ciclofosfamida 500mg  Polv Iny,,1.000,0,1.000,,,600,0,990,0,101%,,.,,1,Frec Check;Doxorrubicina 50mg/25mL (2mg/mL) Sol Iny,,100,100,,,60,99,0,101%,,;;;;;;;;;;;;;2;CICLOfosfamida,DOXOrubicina;AC; AC ,INF,PACLI,semanal,VIDE,5%,25%,90%,100%;Tumor maligno de la mama, parte no especificada;4
3/10/2024;83;1,65;67;1,78;M;Sin Cr;Sin Cr;Docetaxel 20mg/mL Sol Iny,,80,1,50,TRUE,,75,0,89,0,90%,null,,1,15,Inconsistente, según proto: 1;;;;;;;;;;;;;;1;DOCEtaxel;Docetaxel monoQT;DOCE, SC,CREA,CREAT,Suspend;Tumor maligno de la prostata;1
3/10/2024;60;1,6;64;1,72;F;Sin Cr;Sin Cr;Oxaliplatino 100mg/20mL (5mg/mL) Sol Iny,,223,6,130,,,130,0,223,6,100%,null,,1,Frec Check;Oxaliplatino 50mg/10mL (5mg/mL) Sol Iny,,223,6,130,,,130,223,6,100%,null;;;;;;;;;;;;;2;OXALIplatino,OXALIplatino;CAPEOX;CAPEOX,INF;Tumor maligno del colon, parte no especificada;1
3/10/2024;58;1,56;69,6;1,78;F;Sin Cr;Sin Cr;Ciclofosfamida 1gr (1000mg) Polv Iny,,1.068,0,600,,,600,0,1068,0,100%,Aplicar 100 mg IV D1,,1,Frec Check;Doxorrubicina 50mg/25mL (2mg/mL) Sol Iny,,106,8,60,,,60,106,8,100%,Aplicar 100 mg IV D1;;;;;;;;;;;;;2;Ciclofosfamida,DOXOrubicina;AC; AC ,CICLOF,DOXO,DOXO,INF, SC,TAXANO,CREA,CREAT;Tumor maligno de la mama, parte no especificada;1
3/10/2024;55;1,53;47;1,43;F;Sin Cr;Sin Cr;Oxaliplatino 100mg/20mL (5mg/mL) Sol Iny,TRUE,150,0,150,,,130,0,185,9,81%,Oxaliplatino (130 mg/m2). Dosis calculada 150 mg IV. Administrar el dÃ­a 1 de cada ciclo.,,1,Frec Check;;;;;;;;;;;;;;1;OXALIplatino;CAPEOX;Capec,INF,Oxali,PLATINO, SC,VIDE,XELOX,CREA,CREAT;Tumor maligno del colon, parte no especificada;1
3/10/2024;43;1,58;68;1,77;F;Sin Cr;Sin Cr;Doxorrubicina 50mg/25mL (2mg/mL) Sol Iny,,106,2,60,,,60,0,106,2,100%,,,,1,Frec Check;Ciclofosfamida 500mg  Polv Iny,,1062,600,,,600,1062,0,100%,,;;;;;;;;;;;;;2;DOXOrubicina,CICLOfosfamida;AC; AC ,INF,PACLI,10%,100%;Tumor maligno de la mama, parte no especificada;1
4/10/2024;63;1,65;49;1,49;M;Sin Cr;Sin Cr;Fluorouracilo 500 mg/10mL (50mg/mL) Sol Iny,,2.860,8,2.400,,,2.400,0,3576,0,80%,null,,1,15,Frec Check;Fluorouracilo 500 mg/10mL (50mg/mL) Sol Iny,,596,400,,,400,596,0,100%,null;Oxaliplatino 100mg/20mL (5mg/mL) Sol Iny,,101,32,85,,,85,0,126,7,80%,null;Oxaliplatino 50mg/10mL (5mg/mL) Sol Iny,,101,32,85,,,85,126,7,80%,null;Calcio folinato 50mg/5mL (10mg/mL) Sol Iny,,596,400,,,400,596,0,100%,null;;;;;;;;;;5;Fluorouracilo,Fluorouracilo,OXALIplatino,OXALIplatino,Folinato;FOLFOX6modif;FOLFOX,INF,VIDE;Tumor maligno del esofago, parte no especificada;1
4/10/2024;57;1,51;42;1,34;F;Sin Cr;Sin Cr;Fluorouracilo 500 mg/10mL (50mg/mL) Sol Iny,,536,0,400,,,400,0,536,0,100%,null,,1,15,Frec Check;Fluorouracilo 500 mg/10mL (50mg/mL) Sol Iny,,3216,2400,,,2.400,3216,0,100%,null;Oxaliplatino 100mg/20mL (5mg/mL) Sol Iny,,113,9,85,,,85,0,113,9,100%,null;Oxaliplatino 50mg/10mL (5mg/mL) Sol Iny,,113,9,85,,,85,113,9,100%,null;Calcio folinato 50mg/5mL (10mg/mL) Sol Iny,,536,400,,,400,536,0,100%,null;;;;;;;;;;5;Fluorouracilo,Fluorouracilo,OXALIplatino,OXALIplatino,Folinato;FOLFOX6modif;#N/D;Tumor maligno del colon, parte no especificada;2
4/10/2024;69;1,61;70;1,8;M;Sin Cr;Sin Cr;Oxaliplatino 100mg/20mL (5mg/mL) Sol Iny,,234,0,130,,,130,0,234,0,100%,null,,1,Frec Check;Oxaliplatino 50mg/10mL (5mg/mL) Sol Iny,,234,130,,,130,234,0,100%,null;;;;;;;;;;;;;2;OXALIplatino,OXALIplatino;CAPEOX;Capec,INF,Oxali,PLATINO, SC,XELOX;Tumor maligno del recto;2
4/10/2024;50;1,59;65;1,73;F;Sin Cr;Sin Cr;Oxaliplatino 100mg/20mL (5mg/mL) Sol Iny,,224,9,130,,,130,0,224,9,100%,null,,1,Frec Check;Oxaliplatino 50mg/10mL (5mg/mL) Sol Iny,,224,9,130,,,130,224,9,100%,null;;;;;;;;;;;;;2;OXALIplatino,OXALIplatino;CAPEOX;CAPEOX;Tumor maligno del recto;3
4/10/2024;48;1,61;89;2,06;F;Sin Cr;Sin Cr;Trastuzumab Emtansina 100mg Polv iny,,320,4,4,,,3,6,320,4,100%,null,,1,Frec Check;;;;;;;;;;;;;;1;Trastuzumab_Emtansina;Emilia;#N/D;Tumor maligno de la mama, parte no especificada;1
4/10/2024;41;1,58;51;1,51;F;Sin Cr;Sin Cr;Ciclofosfamida 500mg  Polv Iny,,900,0,900,,,600,0,906,0,99%,null,,1,Frec Check;Doxorrubicina 50mg/25mL (2mg/mL) Sol Iny,,90,90,,,60,90,6,99%,null;;;;;;;;;;;;;2;CICLOfosfamida,DOXOrubicina;AC;CICLOF,DOXO,DOXO, SC;Tumor maligno de la mama, parte no especificada;3
4/10/2024;66;1,78;86;2,08;M;Sin Cr;Sin Cr;Docetaxel 20mg/mL Sol Iny,,153,0,75,,,75,0,156,0,98%,null,,1,Frec Check;;;;;;;;;;;;;;1;DOCEtaxel;Docetaxel monoQT;DOCE;Tumor maligno de la prostata;6
4/10/2024;57;1,64;63;1,71;F;Sin Cr;Sin Cr;Oxaliplatino 100mg/20mL (5mg/mL) Sol Iny,,222,3,130,,,130,0,222,3,100%,null,,1,Frec Check;Oxaliplatino 50mg/10mL (5mg/mL) Sol Iny,,222,3,130,,,130,222,3,100%,null;;;;;;;;;;;;;2;OXALIplatino,OXALIplatino;CAPEOX;Capec,Oxali,PLATINO;Tumor maligno del ciego;5
5/10/2024;74;1,62;61;1,68;M;Sin Cr;Sin Cr;Fluorouracilo 500 mg/10mL (50mg/mL) Sol Iny,,672,0,400,,,400,0,672,0,100%,null,,1,15,Frec Check;Fluorouracilo 500 mg/10mL (50mg/mL) Sol Iny,,4032,2400,,,2.400,4032,0,100%,null;Oxaliplatino 50mg/10mL (5mg/mL) Sol Iny,,109,2,65,,,85,0,142,8,76%,ajustado;Calcio folinato 50mg/5mL (10mg/mL) Sol Iny,,672,400,,,400,672,0,100%,null;;;;;;;;;;;4;Fluorouracilo,Fluorouracilo,OXALIplatino,Folinato;FOLFOX6modif;FOLFOX,PLATINO,AJUST;Tumor maligno del colon, parte no especificada;1
5/10/2024;57;1,62;56,4;1,61;F;Sin Cr;Sin Cr;Trastuzumab Emtansina 100mg Polv iny,,200,0,200,,,3,6,203,0,99%,null,,1,22,Inconsistente, según proto: 1;;;;;;;;;;;;;;1;Trastuzumab_Emtansina;Emilia;CARBO,DOCE,INF,MAYO ,PERTU,PLATINO,TrastU,60%;Tumor maligno de la mama, parte no especificada;1
6/10/2024;71;1,66;51;1,53;M;Sin Cr;Sin Cr;Fluorouracilo 500 mg/10mL (50mg/mL) Sol Iny,,612,0,400,,,400,0,612,0,100%,null,,1,15,Frec Check;Fluorouracilo 500 mg/10mL (50mg/mL) Sol Iny,,3672,2400,,,2.400,3672,0,100%,null;Oxaliplatino 50mg/10mL (5mg/mL) Sol Iny,,130,05,85,,,85,0,130,1,100%,null;Calcio folinato 50mg/5mL (10mg/mL) Sol Iny,,612,400,,,400,612,0,100%,null;;;;;;;;;;;4;Fluorouracilo,Fluorouracilo,OXALIplatino,Folinato;FOLFOX6modif;FOLFOX;Tumor maligno del estomago, parte no especificada;2
6/10/2024;50;1,57;65;1,72;F;Sin Cr;Sin Cr;Pertuzumab 420mg/14mL (30mg/mL) Sol Iny,,420,0,420,TRUE,,840,0,420,0,100%,null,,1,22,Inconsistente, según proto: 1;Trastuzumab 440mg Polv Iny,,390,6,,,6,390,0,100%,null;;;;;;;;;;;;;2;PERTUzumab,TRAStuzumab;cleopatra trastuzu IV;CARBO,PACLI,PERTU,PLATINO, RT ,TrastU,20%;Tumor maligno de la mama, parte no especificada;10
6/10/2024;45;1,54;48,8;1,46;M;Sin Cr;Sin Cr;Fluorouracilo 500 mg/10mL (50mg/mL) Sol Iny,,584,0,400,,,400,0,584,0,100%,null,,1,15,Frec Check;Fluorouracilo 500 mg/10mL (50mg/mL) Sol Iny,,3504,2400,,,2.400,3504,0,100%,null;Oxaliplatino 50mg/10mL (5mg/mL) Sol Iny,,86,87,85,,,85,0,124,1,70%,null;Calcio folinato 50mg/5mL (10mg/mL) Sol Iny,,584,400,,,400,584,0,100%,null;;;;;;;;;;;4;Fluorouracilo,Fluorouracilo,OXALIplatino,Folinato;FOLFOX6modif;FOLFOX,INF, RT ,CREA,CREAT;Tumor maligno del recto;5
7/10/2024;37;1,55;55;1,56;F;Sin Cr;Sin Cr;Oxaliplatino 50mg/10mL (5mg/mL) Sol Iny,,200,0,0,,,130,0,202,8,99%,null,,null,Revise recomd, según proto: 1;;;;;;;;;;;;;;1;OXALIplatino;CAPEOX;Capec,Oxali,PLATINO,AJUSTE,AJUST,5%,15%;Tumor maligno del colon, parte no especificada;null
7/10/2024;67;1,64;65;1,74;M;Sin Cr;Sin Cr;Fluorouracilo 500 mg/10mL (50mg/mL) Sol Iny,,4.176,0,2.400,,,2.400,0,4176,0,100%,null,,1,15,Frec Check;Fluorouracilo 500 mg/10mL (50mg/mL) Sol Iny,,696,400,,,400,0,696,0,100%,null;Oxaliplatino 50mg/10mL (5mg/mL) Sol Iny,,147,9,85,,,85,0,147,9,100%,null;Calcio folinato 50mg/5mL (10mg/mL) Sol Iny,,696,400,,,400,0,696,0,100%,null;;;;;;;;;;;4;Fluorouracilo,Fluorouracilo,OXALIplatino,Folinato;FOLFOX6modif;FOLFOX,INF,MAYO ;Tumor maligno del colon, parte no especificada;4
7/10/2024;63;1,65;64;1,73;M;Sin Cr;Sin Cr;Oxaliplatino 50mg/10mL (5mg/mL) Sol Iny,,173,0,100,,,130,0,224,9,77%,null,,1,Frec Check;;;;;;;;;;;;;;1;OXALIplatino;CAPEOX;Capec,INF,Oxali,PLATINO,XELOX,AJUSTE,AJUST;Tumor maligno del recto;4
7/10/2024;70;1,66;59;1,66;M;Sin Cr;Sin Cr;Docetaxel 20mg/mL Sol Iny,,124,5,75,,,75,0,124,5,100%,null,,1,Frec Check;;;;;;;;;;;;;;1;DOCEtaxel;Docetaxel monoQT;DOCE, RT ;Tumor maligno de la prostata;3
7/10/2024;69;1,66;64;1,73;M;Sin Cr;Sin Cr;Oxaliplatino 50mg/10mL (5mg/mL) Sol Iny,,224,9,130,,,130,0,224,9,100%,null,,1,Frec Check;;;;;;;;;;;;;;1;OXALIplatino;CAPEOX;INF,XELOX;Tumor maligno del colon, parte no especificada;4
7/10/2024;53;1,51;75;1,84;F;Sin Cr;Sin Cr;Pertuzumab 420mg/14mL (30mg/mL) Sol Iny,,420,0,420,TRUE,,840,0,420,0,100%,null,,1,Frec Check;Pertuzumab 420mg/14mL (30mg/mL) Sol Iny,,420,420,,,840,0,840,0,50%,null;Trastuzumab 440mg Polv Iny,,450,6,,,6,0,450,0,100%,null;Trastuzumab 440mg Polv Iny,,450,6,,,6,0,450,0,100%,null;Trastuzumab 440mg Polv Iny,,450,6,,,6,0,450,0,100%,null;Pertuzumab 420mg/14mL (30mg/mL) Sol Iny,,420,420,,,840,0,840,0,50%,null;Pertuzumab 420mg/14mL (30mg/mL) Sol Iny,,420,420,,,840,0,840,0,50%,null;Pertuzumab 420mg/14mL (30mg/mL) Sol Iny,,420,420,,,840,0,840,0,50%;;;;;;;8;PERTUzumab,PERTUzumab,TRAStuzumab,TRAStuzumab,TRAStuzumab,PERTUzumab,PERTUzumab,PERTUzumab;cleopatra trastuzu IV;PERTU, RT ,TrastU,50%;Tumor maligno de la mama, parte no especificada;6
7/10/2024;67;1,43;53,7;1,51;F;Sin Cr;Sin Cr;Fluorouracilo 500 mg/10mL (50mg/mL) Sol Iny,,3.624,0,2.400,,,2.400,0,3624,0,100%,null,,1,15,Frec Check;Fluorouracilo 500 mg/10mL (50mg/mL) Sol Iny,,604,400,,,400,0,604,0,100%,null;Oxaliplatino 100mg/20mL (5mg/mL) Sol Iny,,128,35,85,,,85,0,128,4,100%,null;Oxaliplatino 50mg/10mL (5mg/mL) Sol Iny,,128,35,85,,,85,0,128,4,100%,null;Calcio folinato 50mg/5mL (10mg/mL) Sol Iny,,604,400,,,400,0,604,0,100%,null;;;;;;;;;;5;Fluorouracilo,Fluorouracilo,OXALIplatino,OXALIplatino,Folinato;FOLFOX6modif;FOLFOX,INF;Tumor maligno del colon, parte no especificada;2
7/10/2024;55;1,53;62;1,66;F;Sin Cr;Sin Cr;Trastuzumab Emtansina 100mg Polv iny,,223,2,4,,,3,6,223,2,100%,null,,1,22,Inconsistente, según proto: 1;;;;;;;;;;;;;;1;Trastuzumab_Emtansina;Emilia;TrastU,AJUSTE,AJUST,80%;Tumor maligno de la mama, parte no especificada;11
7/10/2024;47;1,63;65;1,74;F;Sin Cr;Sin Cr;Paclitaxel 100mg/16.7mL (6mg/mL) Sol Iny,,140,0,140,,,80,0,139,2,101%,null,,1,8,15,Frec Check;;;;;;;;;;;;;;1;PACLItaxel;Paclitaxel semanal;INF,PACLI;Tumor maligno de la mama, parte no especificada;2
7/10/2024;45;1,65;60;1,67;F;Sin Cr;Sin Cr;Pertuzumab 420mg/14mL (30mg/mL) Sol Iny,,420,0,420,TRUE,,840,0,420,0,100%,,,,1,22,Inconsistente, según proto: 1;Trastuzumab 440mg Polv Iny,,360,360,,,6,0,360,0,100%,Administrar 360 mg iv dia 1 Y 22;;;;;;;;;;;;;2;PERTUzumab,TRAStuzumab;cleopatra trastuzu IV;#N/D;Tumor maligno de la mama, parte no especificada;16
7/10/2024;41;1,55;54;1,55;F;Sin Cr;Sin Cr;Trastuzumab Emtansina 100mg Polv iny,,190,8,4,,,3,6,194,4,98%,null,,1,22,Inconsistente, según proto: 1;;;;;;;;;;;;;;1;Trastuzumab_Emtansina;Emilia;#N/D;Tumor maligno de la mama, parte no especificada;12
7/10/2024;39;1,58;66;1,74;F;Sin Cr;Sin Cr;Trastuzumab Emtansina 100mg Polv iny,,100,0,100,,,3,6,237,6,42%,null,,1,Frec Check;Trastuzumab Emtansina 160mg Polv Iny,,137,137,,,3,6,237,6,58%,null;;;;;;;;;;;;;2;Trastuzumab_Emtansina,Trastuzumab_Emtansina;Emilia;#N/D;Tumor maligno de la mama, parte no especificada;6
7/10/2024;56;1,72;60;1,69;M;Sin Cr;Sin Cr;Fluorouracilo 500 mg/10mL (50mg/mL) Sol Iny,,4.056,0,2.400,,,2.400,0,4056,0,100%,null,,1,15,Frec Check;Fluorouracilo 500 mg/10mL (50mg/mL) Sol Iny,,676,400,,,400,0,676,0,100%,null;Oxaliplatino 50mg/10mL (5mg/mL) Sol Iny,,143,65,85,,,85,0,143,7,100%,null;Calcio folinato 50mg/5mL (10mg/mL) Sol Iny,,676,400,,,400,0,676,0,100%,null;;;;;;;;;;;4;Fluorouracilo,Fluorouracilo,OXALIplatino,Folinato;FOLFOX6modif;FOLFOX;Tumor maligno del estomago, parte no especificada;6
8/10/2024;36;1,62;62;1,69;F;Sin Cr;Sin Cr;Pertuzumab 420mg/14mL (30mg/mL) Sol Iny,,420,0,420,TRUE,,840,0,420,0,100%,null,,1,22,Inconsistente, según proto: 1,1,PERTUzumab,ONCM11,,;Trastuzumab 440mg Polv Iny,,378,6,,,6,0,372,0,102%,null,,1,22,Inconsistente, según proto: 1,1,TRAStuzumab,2854,,;;;;;;;;;;;;;2;PERTUzumab,TRAStuzumab;cleopatra trastuzu IV;PERTU,TrastU;Tumor maligno de la mama, parte no especificada;11
8/10/2024;40;1,8;75;1,94;M;Sin Cr;Sin Cr;Oxaliplatino 100mg/20mL (5mg/mL) Sol Iny,,252,2,130,,,130,0,252,2,100%,null,,1,Frec Check,1,OXALIplatino,4172,,;Oxaliplatino 100mg/20mL (5mg/mL) Sol Iny,,252,2,130,,,130,0,252,2,100%,null,,1,Frec Check,1,OXALIplatino,4172,,;Oxaliplatino 100mg/20mL (5mg/mL) Sol Iny,,252,2,130,,,130,0,252,2,100%,null,,1,Frec Check,1,OXALIplatino,4172,,;;;;;;;;;;;;3;OXALIplatino,OXALIplatino,OXALIplatino;CAPEOX;CAPOX;Tumor maligno del colon, parte no especificada;1
8/10/2024;79;1,66;64;1,73;M;Sin Cr;Sin Cr;Docetaxel 20mg/mL Sol Iny,,97,3,75,,,75,0,129,8,75%,null,,1,Frec Check,1,DOCEtaxel,776,,;;;;;;;;;;;;;;1;DOCEtaxel;Docetaxel monoQT;#N/D;Tumor maligno de la prostata;6
8/10/2024;76;1,75;65,5;1,78;M;Sin Cr;Sin Cr;Docetaxel 20mg/mL Sol Iny,,131,3,75,,,75,0,133,5,98%,null,,1,Frec Check,1,DOCEtaxel,776,,;;;;;;;;;;;;;;1;DOCEtaxel;Docetaxel monoQT;#N/D;Tumor maligno de la prostata;1
8/10/2024;75;1,65;81;1,97;M;Sin Cr;Sin Cr;Docetaxel 20mg/mL Sol Iny,,144,0,75,,,75,0,147,8,97%,null,,1,Frec Check,1,DOCEtaxel,776,,;;;;;;;;;;;;;;1;DOCEtaxel;Docetaxel monoQT;#N/D;Tumor maligno de la prostata;3
8/10/2024;54;1,7;59;1,67;M;Sin Cr;Sin Cr;Docetaxel 20mg/mL Sol Iny,,100,2,75,,,75,0,125,3,80%,null,,1,Frec Check,1,DOCEtaxel,776,,;;;;;;;;;;;;;;1;DOCEtaxel;Docetaxel monoQT;DOCE,INF,AJUSTE,AJUST,80%,100%,CREA,CREAT;Tumor maligno de la prostata;2
8/10/2024;56;1,47;60,7;1,62;F;Sin Cr;Sin Cr;Pertuzumab 420mg/14mL (30mg/mL) Sol Iny,,420,0,420,TRUE,,840,0,420,0,100%,.,,1,22,Inconsistente, según proto: 1,1,PERTUzumab,ONCM11,,;Trastuzumab 440mg Polv Iny,,360,6,,,6,0,364,2,99%,.,,1,22,Inconsistente, según proto: 1,1,TRAStuzumab,2854,,;;;;;;;;;;;;;2;PERTUzumab,TRAStuzumab;cleopatra trastuzu IV; AC ,INF,PERTU,TC ,TrastU,50%;Tumor maligno de la mama, parte no especificada;6
8/10/2024;63;1,56;56;1,58;F;Sin Cr;Sin Cr;Oxaliplatino 100mg/20mL (5mg/mL) Sol Iny,,205,4,130,,,130,0,205,4,100%,null,,1,Frec Check,1,OXALIplatino,4172,,;;;;;;;;;;;;;;1;OXALIplatino;CAPEOX;#N/D;Tumor maligno del colon, parte no especificada;1
8/10/2024;61;1,45;55;1,53;F;Sin Cr;Sin Cr;Ciclofosfamida 1gr (1000mg) Polv Iny,,826,2,600,,,600,0,918,0,90%,null,,1,Frec Check,1,Ciclofosfamida,1171,,;Doxorrubicina 50mg/25mL (2mg/mL) Sol Iny,,82,62,60,,,60,0,91,8,90%,null,,1,Frec Check,1,DOXOrubicina,4838,,;;;;;;;;;;;;;2;Ciclofosfamida,DOXOrubicina;AC; AC ,INF,40%,100%;Tumor maligno de la mama, parte no especificada;4
8/10/2024;44;1,44;49;1,44;F;Sin Cr;Sin Cr;Pertuzumab 420mg/14mL (30mg/mL) Sol Iny,,420,0,420,TRUE,,840,0,420,0,100%,,,,1,22,Inconsistente, según proto: 1,1,PERTUzumab,ONCM11,,;Trastuzumab 440mg Polv Iny,TRUE,6,6,FALSE,,6,0,294,0,2%,,,,1,22,Inconsistente, según proto: 1,1,TRAStuzumab,2854,,;;;;;;;;;;;;;2;PERTUzumab,TRAStuzumab;cleopatra trastuzu IV; AC , CAP ,CARBO,INF,PACLI,PERTU,TrastU,90%;Tumor maligno de la mama, parte no especificada;9
8/10/2024;51;1,4;70;1,73;F;Sin Cr;Sin Cr;Paclitaxel 100mg/16.7mL (6mg/mL) Sol Iny,,138,4,80,,,80,0,138,4,100%,null,,1,8,15,Frec Check,1,8,15,PACLItaxel,2385,,;;;;;;;;;;;;;;1;PACLItaxel;Paclitaxel semanal;PACLI,semanal,TAXANO,AJUSTE,AJUST,70%,80%,100%;Tumor maligno de la mama, parte no especificada;2
8/10/2024;49;1,56;44;1,38;F;Sin Cr;Sin Cr;Ciclofosfamida 1gr (1000mg) Polv Iny,,828,0,600,,,600,0,828,0,100%,null,,1,Frec Check,1,Ciclofosfamida,1171,,;Ciclofosfamida 500mg  Polv Iny,,828,600,,,600,0,828,0,100%,null,,1,Frec Check,1,CICLOfosfamida,852,,;Pembrolizumab 100mg/4mL (25mg/mL) Sol Iny,TRUE,88,2,,,200,0,200,0,44%,null,,1,Frec Check,1,PEMBROlizumab,ONCM74,,;Doxorrubicina 50mg/25mL (2mg/mL) Sol Iny,,82,8,60,,,60,0,82,8,100%,null,,1,Frec Check,1,DOXOrubicina,4838,,;;;;;;;;;;;4;Ciclofosfamida,CICLOfosfamida,PEMBROlizumab,DOXOrubicina;AC; AC ,PEMBRO,80%,100%;Tumor maligno de la mama, parte no especificada;3
8/10/2024;43;1,75;70;1,85;M;Sin Cr;Sin Cr;Oxaliplatino 50mg/10mL (5mg/mL) Sol Iny,,244,4,130,,,130,0,240,5,102%,null,,1,Frec Check,1,OXALIplatino,258,,;;;;;;;;;;;;;;1;OXALIplatino;CAPEOX;CAPEOX,INF;Tumor maligno del estomago, parte no especificada;6
8/10/2024;59;1,66;78;1,93;M;Sin Cr;Sin Cr;Docetaxel 20mg/mL Sol Iny,,144,8,75,,,75,0,144,8,100%,null,,1,Frec Check,1,DOCEtaxel,776,,;;;;;;;;;;;;;;1;DOCEtaxel;Docetaxel monoQT;DOCE,INF,TCH ;Tumor maligno de la prostata;1
9/10/2024;28;1,52;43;1,36;F;Sin Cr;Sin Cr;Ciclofosfamida 1gr (1000mg) Polv Iny,,822,0,600,,,600,0,816,0,101%,null,,1,Frec Check,1,Ciclofosfamida,1171,,;Doxorrubicina 50mg/25mL (2mg/mL) Sol Iny,,82,2,60,,,60,0,81,6,101%,null,,1,Frec Check,1,DOXOrubicina,4838,,;;;;;;;;;;;;;2;Ciclofosfamida,DOXOrubicina;AC; AC ,INF,semanal,TAXANO,20%,100%;Tumor maligno de la mama, parte no especificada;4
9/10/2024;77;1,67;60,2;1,68;M;Sin Cr;Sin Cr;Docetaxel 20mg/mL Sol Iny,,126,0,75,,,75,0,126,0,100%,null,,1,Frec Check,1,DOCEtaxel,776,,;;;;;;;;;;;;;;1;DOCEtaxel;Docetaxel monoQT;#N/D;Tumor maligno de la prostata;1
9/10/2024;73;1,6;57;1,61;M;Sin Cr;Sin Cr;Docetaxel 20mg/mL Sol Iny,,120,8,75,,,75,0,120,8,100%,null,,1,Frec Check,1,DOCEtaxel,776,,;;;;;;;;;;;;;;1;DOCEtaxel;Docetaxel monoQT;DOCE, SC,CREA,CREAT;Tumor maligno de la prostata;4
9/10/2024;76;1,57;62;1,68;F;Sin Cr;Sin Cr;Oxaliplatino 100mg/20mL (5mg/mL) Sol Iny,,218,4,130,,,130,0,218,4,100%,null,,1,Frec Check,1,OXALIplatino,4172,,;;;;;;;;;;;;;;1;OXALIplatino;CAPEOX;Beva,CAPEOX,INF;Tumor maligno del recto;1
9/10/2024;81;1,66;82;1,99;M;Sin Cr;Sin Cr;Docetaxel 20mg/mL Sol Iny,,126,9,75,,,75,0,149,3,85%,null,,1,Frec Check,1,DOCEtaxel,776,,;;;;;;;;;;;;;;1;DOCEtaxel;Docetaxel monoQT;DOCE,TAXANO;Tumor maligno de la prostata;3
9/10/2024;58;1,71;70;1,84;M;Sin Cr;Sin Cr;Oxaliplatino 100mg/20mL (5mg/mL) Sol Iny,,239,2,130,,,130,0,239,2,100%,null,,1,Frec Check,1,OXALIplatino,4172,,;;;;;;;;;;;;;;1;OXALIplatino;CAPEOX;CAPEOX,MAYO ;Tumor maligno del colon, parte no especificada;5
9/10/2024;85;1,62;58;1,63;M;Sin Cr;Sin Cr;Oxaliplatino 50mg/10mL (5mg/mL) Sol Iny,,169,5,130,,,130,0,211,9,80%,null,,1,Frec Check,1,OXALIplatino,258,,;Oxaliplatino 100mg/20mL (5mg/mL) Sol Iny,,169,52,130,,,130,0,211,9,80%,null,,1,Frec Check,1,OXALIplatino,4172,,;Oxaliplatino 50mg/10mL (5mg/mL) Sol Iny,,169,52,130,,,130,0,211,9,80%,null,,1,Frec Check,1,OXALIplatino,258,,;Oxaliplatino 100mg/20mL (5mg/mL) Sol Iny,,169,52,130,,,130,0,211,9,80%,null,,1,Frec Check,1,OXALIplatino,4172,,;Oxaliplatino 100mg/20mL (5mg/mL) Sol Iny,,169,52,130,,,130,0,211,9,80%,null,,1,Frec Check,1,OXALIplatino,4172,,;Oxaliplatino 100mg/20mL (5mg/mL) Sol Iny,,169,52,130,,,130,0,211,9,80%,null,,1,Frec Check,1,OXALIplatino,4172,,,;;;;;;;;;6;OXALIplatino,OXALIplatino,OXALIplatino,OXALIplatino,OXALIplatino,OXALIplatino;CAPEOX;#N/D;Tumor maligno de la prostata;1
9/10/2024;38;1,56;83;1,96;F;Sin Cr;Sin Cr;Pertuzumab 420mg/14mL (30mg/mL) Sol Iny,,420,0,420,TRUE,,840,0,420,0,100%,null,,1,22,Inconsistente, según proto: 1,1,PERTUzumab,ONCM11,,;Trastuzumab 440mg Polv Iny,,498,6,,,6,0,498,0,100%,null,,1,22,Inconsistente, según proto: 1,1,TRAStuzumab,2854,,;;;;;;;;;;;;;2;PERTUzumab,TRAStuzumab;cleopatra trastuzu IV;#N/D;Tumor maligno de la mama, parte no especificada;8
9/10/2024;77;1,48;44;1,36;F;Sin Cr;Sin Cr;Paclitaxel 30mg/5mL (6mg/mL) Sol Iny,,108,8,80,,,80,0,108,8,100%,null,,1,8,15,Frec Check,1,8,15,PACLItaxel,1456,,;;;;;;;;;;;;;;1;PACLItaxel;Paclitaxel semanal;DOXO,DOXO,INF,PACLI,semanal,TAXANO,20%,100%;Tumor maligno de la mama, parte no especificada;2
9/10/2024;62;1,69;71;1,85;F;Sin Cr;Sin Cr;Docetaxel 20mg/mL Sol Iny,,131,3,75,,,75,0,138,8,95%,,,,1,Frec Check,1,DOCEtaxel,776,,;;;;;;;;;;;;;;1;DOCEtaxel;Docetaxel monoQT;Capec,CARBO,DOCE,INF,monoagente,PLATINO,70%;Tumor maligno de la mama, parte no especificada;1
9/10/2024;58;1,55;56;1,58;F;Sin Cr;Sin Cr;Doxorrubicina 50mg/25mL (2mg/mL) Sol Iny,,93,6,60,,,60,0,94,8,99%,null,,1,Frec Check,1,DOXOrubicina,4838,,;Ciclofosfamida 1gr (1000mg) Polv Iny,,936,600,,,600,0,948,0,99%,null,,1,Frec Check,1,Ciclofosfamida,1171,,;Ciclofosfamida 1gr (1000mg) Polv Iny,,936,600,,,600,0,948,0,99%,null,,1,Frec Check,1,Ciclofosfamida,1171,,;Ciclofosfamida 1gr (1000mg) Polv Iny,,936,600,,,600,0,948,0,99%,null,,1,Frec Check,1,Ciclofosfamida,1171,,;;;;;;;;;;;4;DOXOrubicina,Ciclofosfamida,Ciclofosfamida,Ciclofosfamida;AC; AC ,40%;Tumor maligno de la mama, parte no especificada;3
9/10/2024;51;1,52;69;1,76;F;Sin Cr;Sin Cr;Ciclofosfamida 500mg  Polv Iny,,1.056,0,600,,,600,0,1056,0,100%,null,,1,Frec Check,1,CICLOfosfamida,852,,;Doxorrubicina 50mg/25mL (2mg/mL) Sol Iny,,105,6,60,,,60,0,105,6,100%,null,,1,Frec Check,1,DOXOrubicina,4838,,;;;;;;;;;;;;;2;CICLOfosfamida,DOXOrubicina;AC; AC ,INF,70%,100%;Tumor maligno de la mama, parte no especificada;4
9/10/2024;68;1,64;64;1,73;M;Sin Cr;Sin Cr;Docetaxel 20mg/mL Sol Iny,,129,8,75,,,75,0,129,8,100%,null,,1,Frec Check,1,DOCEtaxel,776,,;;;;;;;;;;;;;;1;DOCEtaxel;Docetaxel monoQT;DOCE, SC;Tumor maligno de la prostata;6
9/10/2024;44;1,73;54;1,6;M;Sin Cr;Sin Cr;Oxaliplatino 100mg/20mL (5mg/mL) Sol Iny,,187,2,130,,,130,0,208,0,90%,null,,1,Frec Check,1,OXALIplatino,4172,,;;;;;;;;;;;;;;1;OXALIplatino;CAPEOX;CAPEOX,INF,PLATINO,AJUST,10%;Tumor maligno del estomago, parte no especificada;5
